Verburg Frederik A, Mäder Uwe, Luster Markus, Reiners Christoph
Department of Nuclear Medicine, Würzburg University, Würzburg, Germany.
Eur J Endocrinol. 2009 Apr;160(4):619-24. doi: 10.1530/EJE-08-0805. Epub 2009 Jan 21.
Papillary thyroid carcinoma (PTC) and follicular thyroid carcinoma (FTC) show considerable differences in disease stage at initial presentation. The aim of this study was to investigate whether there are differences in tumour-specific survival if initial staging is accounted for.
Retrospective chart review study.
The study sample comprised 875 PTC and 350 FTC patients (856 females, 369 males, mean age 47.8 years) treated in our hospital from 1978 to 2002. All patients received total thyroidectomy with subsequent I-131 ablation except for those patients with an isolated papillary microcarcinoma.
Kaplan-Meier analyses and Cox-regression analyses were performed to assess the influence of histology on thyroid cancer-specific survival.
FTC patients were on average older, more likely to be male, presented with a larger tumour and more frequently had multifocal carcinoma and distant metastases than PTC patients, whereas they presented less frequently with extrathyroidal invasion or lymph node metastases. Twenty-year tumour-specific survival in PTC was 90.6% and in FTC 73.7% (P<0.001). In multivariate analysis the presence of distant metastases (P<0.001), age (P<0.001), tumour size (P=0.001) and the presence of extrathyroidal invasion (P=0.007), but not histology (P=0.26), were independent determinant variables for tumour-specific survival.
There is no difference in tumour-specific survival between PTC and FTC when accounting for the presence of metastases, age, tumour size and the presence of extrathyroidal invasion.
甲状腺乳头状癌(PTC)和甲状腺滤泡状癌(FTC)在初次就诊时疾病分期存在显著差异。本研究旨在探讨如果考虑初始分期,肿瘤特异性生存率是否存在差异。
回顾性病历审查研究。
研究样本包括1978年至2002年在我院接受治疗的875例PTC患者和350例FTC患者(856例女性,369例男性,平均年龄47.8岁)。除孤立性乳头状微小癌患者外,所有患者均接受了甲状腺全切术及后续的I - 131消融治疗。
进行Kaplan - Meier分析和Cox回归分析,以评估组织学对甲状腺癌特异性生存的影响。
与PTC患者相比,FTC患者平均年龄更大,男性比例更高,肿瘤更大,多灶性癌和远处转移更常见,而甲状腺外侵犯或淋巴结转移较少见。PTC患者的20年肿瘤特异性生存率为90.6%,FTC患者为73.7%(P<0.001)。多变量分析中,远处转移的存在(P<0.001)、年龄(P<0.001)、肿瘤大小(P = 0.001)和甲状腺外侵犯的存在(P = 0.007)是肿瘤特异性生存的独立决定变量,而组织学(P = 0.26)不是。
当考虑转移的存在、年龄、肿瘤大小和甲状腺外侵犯的存在时,PTC和FTC的肿瘤特异性生存率没有差异。